钒化合物调节RAW264.7细胞中热休克蛋白60诱导的IL-6释放

doi:10.5246/jcps.2015.01.003

中国药学(英文版) ›› 2015, Vol. 24 ›› Issue (1): 28-33.DOI: 10.5246/jcps.2015.01.003

钒化合物调节RAW264.7细胞中热休克蛋白60诱导的IL-6释放

郭巍, 杨晓达^*

北京大学医学部药学院化学生物学系; 天然药物及仿生药物国家重点实验室, 北京 100191

收稿日期:2014-08-28 修回日期:2014-09-10 出版日期:2015-01-15 发布日期:2014-10-06
通讯作者: Tel.: 86-10-82801539, Fax: 86-10-62015584
基金资助:
National Natural Science Foundation of China (Grant No. 21271012).

Vanadium regulates HSP60-induced IL-6 release from RAW264.7 cells in a dose-dependent manner

Wei Guo, Xiaoda Yang^*

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2014-08-28 Revised:2014-09-10 Online:2015-01-15 Published:2014-10-06
Contact: Tel.: 86-10-82801539, Fax: 86-10-62015584
Supported by:
National Natural Science Foundation of China (Grant No. 21271012).

摘要/Abstract

摘要：

钒化合物是具有前景的抗糖尿病候选药物, 但其药理作用机制尚未完全阐明。在I型和II型糖尿病发病过程中, 炎症和自免疫紊乱可能发挥了重要作用; 其中热休克蛋白60 (HSP60)是关键的内源性促炎因子之一。本文研究了偏钒酸钠和硫酸氧钒两种化合物对RAW264.7巨噬细胞在HSP60刺激下分泌白细胞介素6 (IL-6)的作用。结果表明, 两种钒化合物均可浓度依赖的调节IL-6的表达。然而, 钒化合物的作用并没有通过NF-κB和PPAR-γ 这两种常见的炎症信号调节机制。本文结果提示, 钒化合物调节免疫的作用可能与其抗糖尿病药理作用机制有关, 值得深入的研究阐明。

关键词: 钒化合物, 热休克蛋白60, 白细胞介素6

Abstract:

Vanadium compounds are promising anti-diabetic agents. However, the underlying mechanisms have not been fully elucidated. Inflammation and auto-immune disorders play important roles in the progresses of both type I and type II diabetes, in which heat shock protein 60 (HSP60) is an important endogenous inflammatory mediator. In the present work, we investigated the effects of vanadium compounds (vanadyl sulfate and sodium metavanadate) on the IL-6 production in RAW264.7 cells upon HSP60 stimulation. Our data revealed that both vanadyl ions regulated the IL-6 expression in a concentration-dependent manner. However, the two common NF-κB and PPAR-γ signal pathways were not involved in this process. Further works are needed to elucidate the underlying mechanism and significance of the immuno-modification actions for the pharmacological applications of anti-diabetic vanadium compounds.

Key words: Vanadyl ions, Heat shock protein 60, Interleukin-6

中图分类号:

R915

Supporting:

郭巍, 杨晓达. 钒化合物调节RAW264.7细胞中热休克蛋白60诱导的IL-6释放[J]. 中国药学(英文版), 2015, 24(1): 28-33.

Wei Guo, Xiaoda Yang. Vanadium regulates HSP60-induced IL-6 release from RAW264.7 cells in a dose-dependent manner[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(1): 28-33.

参考文献

[1] Rehder, D. Future Med. Chem. 2012, 4, 1823-1837.

[2] Willsky, G.R.; Goldfine, A.B.; Kostyniak, P.J.; McNeill, J.H.; Yang, L.Q.; Khan, H.R.; Crans, D.C. J. Inorg. Biochem. 2001, 85, 33-42.

[3] Evangelou, A.M. Crit. Rev. Oncol. Hematol. 2002, 42, 249-265.

[4] Zhao, Y.B.; Shi, Z.; Ye, L.H.; Liu, H.X.; Yang, X.D.; Wang, K. J. Chin. Pharm. Sci. 2009, 18, 225-231.

[5] Shi, Z.; Liu, H.; Yang, X. J. Chin. Pharm. Sci. 2011, 20, 498-504.

[6] Srivastava, A.K.; Mehdi, M.Z. Diabet. Med. 2005, 22, 2-13.

[7] Donath, M.Y. Nat. Rev. Drug Discov. 2014, 13, 465-476.

[8] Takenaka, R.; Yokota, K.; Ayada, K.; Mizuno, M.; Zhao, Y.; Fujinami, Y.; Lin, S.N.; Toyokawa, T.; Okada, H.; Shiratori, Y.; Oguma, K. Microbiology. 2004, 150, 3913-3922.

[9] Marker, T.; Sell, H.; Zillessen, P.; Glöde, A.; Kriebel, J.; Ouwens, D.M.; Pattyn, P.; Ruige, J.; Famulla, S.; Roden, M.; Eckel, J.; Habich, C. Diabetes. 2012, 61, 615-625.

[10] Van, H.A.; Mosselman, B.; Roep, B.O.; Van, E.W.; Cooke, A.; Kraal, G.; Wauben, M.H. J. Immunol. 2000, 165, 5544-5551.

[11] Imatoh, T.; Sugie, T.; Miyazaki, M.; Tanihara, S.; Baba, M.; Momose, Y.; Uryu, Y.; Une, H. Diabetes Res. Clin. Pract. 2009, 85, 208-212.

[12] Blasi, C.; Kim, E.; Knowlton, A.A. Autoimmune Dis. 2012, 2012, 346501.

[13] Lei, W.H.; Liu, H.X.; Zhong, L.J.; Yang, X.D.; Wang, K. Chin. Sci. Bull. 2007, 1246-1251.

[14] Barceloux, D.G. J. Toxicol. Clin. Toxicol. 1999, 37, 265-278.

[15] Russe, O.Q.; Moser, C.V.; Kynast, K.L.; King, T.S.; Olbrich, K.; Grösch, S.; Geisslinger, G.; Niederberger, E. Biochem. Biophys. Res. Commun. 2014, 447, 520-525.

[16] Yoon, J.W.; Jun, H.S. Arch. Pharm. Res. 1999, 22, 437-447.

[17] Rabinovitch, A.; Suarez-Pinzon, W.L. Cell Biochem. Biophys. 2007, 48, 159-163.

[18] Yoo, J.S.; Lee, Y.J.; Hyung, K.E.; Yoon, J.W.; Lee, I.H.; Park, S.Y.; Hwang, K.W. Korean J. Physiol. Pharmacol. 2012, 16, 463-468.

[19] Lee, J.; Nakagiri, T.; Oto, T.; Harada, M.; Morii, E.; Shintani, Y.; Inoue, M.; Iwakura, Y.; Miyoshi, S.; Okumura, M.; Hirano, T.; Murakami, M. J. Immunol. 2012, 189, 1928-1936.

[20] Murakami, M.; Hirano, T. Int. J. Biol. Sci. 2012, 8, 1267-1280.

[21] Chinetti, G.; Fruchart, J.C.; Staels, B. Inflamm. Res. 2000, 49, 497-505.

[22] Zhao, P.; Yang, X. Metallomics. 2013, 5, 836-843.

[23] Wu, Y.; Huang, M.; Zhao, P.; Yang, X. J. Biol. Inorg. Chem. 2013, 18, 623-631.

[24] Misra, U.K.; Pizzo, S.V. J. Leukoc. Biol. 2005, 78, 187-194.

[25] Ferguson-Smith, A.C.; Chen, Y.F.; Newman, M.S.; May, L.T.; Sehgal, P.B.; Ruddle, F.H. Genomics. 1988, 2, 203-208.

[26] Carey, A.L.; Steinberg, G.R.; Macaulay, S.L.; Thomas, W.G.; Holmes, A.G.; Ramm, G.; Prelovsek, O.; Hohnen-Behrens, C.; Watt, M.J.; James, D.E.; Kemp, B.E.; Pedersen, B.K.; Febbraio, M.A. Diabetes. 2006, 55, 2688-2697.

[27] Petersen, A.M.; Pedersen, B.K. J. Physiol. Pharmacol. 2006, 57, 43-51.

[28] Pedersen, B.K. Biochem. Soc. Trans. 2007, 35, 1295-1297.

[29] O, N.L. Curr. Opin. Immunol. 2006, 18, 3-9.

[30] Cao, J.R.; Sun, S.L.; Ju, Y.C. J. Toxicol (Chin). 2009, 4, 308-310.

钒化合物调节RAW264.7细胞中热休克蛋白60诱导的IL-6释放

Vanadium regulates HSP60-induced IL-6 release from RAW264.7 cells in a dose-dependent manner

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	洪艺华, 刘曈彤, 刘彦君, 吴竞轩, 杨晓改. 钒化合物通过活性氧水平的调节对PTEN表达缺失的前列腺癌细胞发挥更强的抑制作用[J]. 中国药学(英文版), 2017, 26(6): 432-439.
[2]	李雪, 白力丹, 董雅琼, 常青, 武睿, 章京, 杨晓达. 钒化合物与肉桂醛共同作用改善β淀粉样蛋白损伤的SHSY5Y神经细胞活力[J]. 中国药学(英文版), 2016, 25(10): 754-763.
[3]	李逸, 刘竟成, 于游, 卞卫霞, 胡霞, 杨晓改. 乙酰丙酮氧钒化合物诱导的活性氧生成在3T3L1脂肪细胞脂解和糖代谢过程中的调节作用[J]. 中国药学(英文版), 2015, 24(11): 726-733.
[4]	霍辰伊, 刘会雪. Amavadin诱导大鼠肾线粒体通透性转换孔开放与活性氧生成无关[J]. 中国药学(英文版), 2014, 23(12): 830-836.